DE69833118D1 - IMMUNOASSAY TO DETERMINE BNP - Google Patents

IMMUNOASSAY TO DETERMINE BNP

Info

Publication number
DE69833118D1
DE69833118D1 DE69833118T DE69833118T DE69833118D1 DE 69833118 D1 DE69833118 D1 DE 69833118D1 DE 69833118 T DE69833118 T DE 69833118T DE 69833118 T DE69833118 T DE 69833118T DE 69833118 D1 DE69833118 D1 DE 69833118D1
Authority
DE
Germany
Prior art keywords
bnp
immunoassay
mammalian
gamma
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833118T
Other languages
German (de)
Other versions
DE69833118T2 (en
Inventor
Hidehisa Asada
Santaun-Oyashiki Shimizu
Kazuaki Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69833118(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE69833118D1 publication Critical patent/DE69833118D1/en
Publication of DE69833118T2 publication Critical patent/DE69833118T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

An immunoassay specific for mammalian gamma -BNP derivatives, which uses the first antibody reactive with mammalian alpha -BNP and the second antibody reactive with mammalian prepro-BNP or gamma -BNP derivatives and not alpha -BNP, and at least one of the first and the second antibodies is optionally labeled detectably labeled or immobilized. <IMAGE>
DE69833118T 1997-09-11 1998-09-10 IMMUNOASSAY TO DETERMINE BNP Expired - Lifetime DE69833118T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11
JP24668497 1997-09-11
PCT/JP1998/004063 WO1999013331A1 (en) 1997-09-11 1998-09-10 Immunoassay method for bnp

Publications (2)

Publication Number Publication Date
DE69833118D1 true DE69833118D1 (en) 2006-03-30
DE69833118T2 DE69833118T2 (en) 2006-08-31

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833118T Expired - Lifetime DE69833118T2 (en) 1997-09-11 1998-09-10 IMMUNOASSAY TO DETERMINE BNP

Country Status (13)

Country Link
US (1) US6828107B2 (en)
EP (1) EP1016867B1 (en)
JP (1) JP3516655B2 (en)
KR (1) KR100563358B1 (en)
CN (1) CN1161609C (en)
AT (1) ATE315228T1 (en)
AU (1) AU731858B2 (en)
CA (1) CA2304263C (en)
DE (1) DE69833118T2 (en)
DK (1) DK1016867T3 (en)
ES (1) ES2256952T3 (en)
NO (1) NO325020B1 (en)
WO (1) WO1999013331A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (en) * 2002-03-14 2005-09-07 三洋化成工業株式会社 Method for quantifying heart failure markers in blood
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
AU2003234407B2 (en) 2002-05-09 2008-12-18 The Brigham And Women's Hospital, Inc. 1L1RL-1 as a cardiovascular disease marker and therapeutic target
FR2843396B1 (en) * 2002-08-07 2005-04-15 Bio Rad Pasteur SPECIFIC ANTIBODIES FOR THE DIAGNOSIS OF HEART FAILURE
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
PT1638443E (en) * 2003-06-20 2011-01-25 Mayo Foundation Isoforms of brain natriuretic peptide
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (en) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． Novel variant of brain natriuretic peptide and method of use thereof
EP2264463A3 (en) * 2004-03-19 2011-08-10 Biomedica Medizinprodukte GmbH & Co KG Prognostic methods for congestive heart failure
AT500800B1 (en) 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh PROCESS FOR DETERMINING PROBNP
EP1794588A2 (en) * 2004-09-09 2007-06-13 Biosite Incorporated Methods and compositions for measuring canine bnp and uses thereof
US7731965B2 (en) 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
JP5364378B2 (en) 2005-11-09 2013-12-11 アボット・ラボラトリーズ Human BNP immunospecific antibody
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
EP2386860B1 (en) 2006-04-24 2014-11-05 Critical Care Diagnostics, Inc. Predicting mortality and detecting severe disease
EP2021796B1 (en) * 2006-05-01 2012-02-08 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
WO2008021872A1 (en) * 2006-08-08 2008-02-21 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095046A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (en) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh PROCESS FOR DETERMINING PROBNP
FI20075251A0 (en) * 2007-04-13 2007-04-13 Hytest Oy Immunoassay for the detection of unstable antigens
CA2686867A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
SI2269063T1 (en) 2008-04-18 2014-01-31 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
US20090299401A1 (en) 2008-06-02 2009-12-03 Loma Vista Medical, Inc. Inflatable medical devices
US20110270530A1 (en) * 2008-12-08 2011-11-03 Seok-Won Lee Combined natriuretic peptide assays
CN101923090A (en) * 2009-06-10 2010-12-22 中国科学院电子学研究所 Method for preparing optical sensitive film for fixing human brain natriuretic peptide (BNP)
WO2012009486A2 (en) 2010-07-13 2012-01-19 Loma Vista Medical, Inc. Inflatable medical devices
EP2601531A1 (en) 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Detection of degradation products of canine nt-probnp
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
EP2715353B1 (en) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
KR20140059249A (en) 2011-08-30 2014-05-15 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 Natriuretic polypeptides
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
IN2015DN01767A (en) 2012-08-21 2015-05-29 Critical Care Diagnostics Inc
CN112710852B (en) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 GNP polypeptide detection kit and detection method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (en) * 1990-04-16 1997-11-12 塩野義製薬株式会社 Monoclonal antibody recognizing hBNP and immunoassay method for hBNP using the antibody
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
DE69833118T2 (en) 2006-08-31
EP1016867B1 (en) 2006-01-04
CN1278919A (en) 2001-01-03
KR100563358B1 (en) 2006-03-22
EP1016867A4 (en) 2004-11-17
ES2256952T3 (en) 2006-07-16
US6828107B2 (en) 2004-12-07
KR20010023853A (en) 2001-03-26
NO325020B1 (en) 2008-01-14
NO20001273D0 (en) 2000-03-10
CN1161609C (en) 2004-08-11
DK1016867T3 (en) 2006-05-22
WO1999013331A1 (en) 1999-03-18
NO20001273L (en) 2000-05-10
EP1016867A1 (en) 2000-07-05
JP3516655B2 (en) 2004-04-05
AU9001098A (en) 1999-03-29
CA2304263A1 (en) 1999-03-18
US20030157596A1 (en) 2003-08-21
AU731858B2 (en) 2001-04-05
CA2304263C (en) 2008-07-29
ATE315228T1 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
ATE315228T1 (en) IMMUNOASSAY TO DETERMINE BNP
ATE223054T1 (en) ASSAY USING POROSITY REDUCTION TO PREVENT MIGRATION
DE59409947D1 (en) Reduction of the hook effect in immunoassays with particulate carrier material
FI954029A (en) Chemiluminescent reagent and method of analysis using substituted acetanilide for light generation
EP0113075A3 (en) Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith
ES2194139T3 (en) INCREASE OF SENSITIVITY IN THE IMMUNOCHEMICAL DETERMINATION OF AN ANALYTE.
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
ATE254286T1 (en) TWO-INCUBATION IMMUNOASSAY USING LABELED ANTIGEN
ES2023868B3 (en) IMMUNOMETRIC DETERMINATION PROCEDURE
DE69310667T2 (en) Immunoassay method using photothermal beam deflection spectroscopy
ES2094784T3 (en) PROCEDURE FOR THE DETERMINATION OF AN ANALYTE.
DE59109139D1 (en) Immunological detection of metolachlor
DE59606685D1 (en) Competitive immunoassay using complex analyte derivatives
ATE286596T1 (en) CHEMICAL MODIFICATION OF ANTIBODIES AND ANTIGENS
KR860007545A (en) Method for quantifying human prolyl 4-hydroxylase
DE68919521T2 (en) Immunoassay for the detection of alpha-haloacetamides.
DE69727975D1 (en) 5-HYDROXYTRYPTOPHOL (5-HTOL) DERIVATIVES, ANTIBODIES, IMMUNOASSAYS AND DETECTION OF SHORT-TERM ALCOHOL CONSUMPTION
FI904304A0 (en) FOERFARANDE FOER PAOVISANDE AV ANALYTER.
JPS5386014A (en) Quantitative analysis of antigen and antibody
AU7943091A (en) Immunological detection methods

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings